Free shipping on all orders over $ 500

GSK591

Cat. No. M8649

All AbMole products are for research use only, cannot be used for human consumption.

GSK591 Structure
Synonym:

GSK-591; GSK3203591; EPZ015866

Size Price Availability Quantity
1mg USD 55  USD55 In stock
5mg USD 104  USD104 In stock
10mg USD 178  USD178 In stock
25mg USD 325  USD325 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GSK591 (EPZ015866) is a SGC probe for PRMT5. GSK591 is a potent and selective inhibitor of H4 histone methylation by PRMT5/MEP50 complex. GSK591 (5 μM; MCF7, T47D, and MCF10A cells) treatment suppresses breast cancer stem cells (BCSCs) proliferation and self-renewal. GSK591 reduces BCSCs numbers in vitro. In Z-138 cells, GSK591 inhibits the symmetric arginine methylation of SmD3 with EC50 of 56 nM.

Product Citations
Chemical Information
Molecular Weight 380.48
Formula C22H28N4O2
CAS Number 1616391-87-7
Solubility (25°C) DMSO 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jianhao Huang, et al. PRMT5 Promotes EMT Through Regulating Akt Activity in Human Lung Cancer

[2] Liu Yang, et al. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression

[3] Patty Sachamitr, et al. PRMT5 inhibition disrupts splicing and stemness in glioblastoma

[4] Yongrong Yan, et al. PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades

[5] Shikui Zhang, et al. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth

Related PRMTs Products
AMG-193

AMG-193 is an orally active inhibitor of the PRMT5/MTA complex for studies related to solid tumors. AMG-193 (PRMT5-IN-27) inhibits HCT116 cell proliferation with an IC 50 of 0.13 μM.

AZD3470

AZD3470 is a novel PRMT5 inhibitor targeting the MTA and PRMT5 complex for studies related to hematologic tumors.

TNG-462

TNG-462 is an orally active PRMT5 inhibitor for investigation of MTAP-deficient and/or MTA-accumulating cancers.

TNG908

TNG908 (Ralometostat) is a PRMT5 inhibitor that crosses the blood-brain barrier and can be used in studies related to advanced solid tumors.

PRMT5-IN-20 

PRMT5-IN-20 is a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with anti-tumor activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK591, GSK-591; GSK3203591; EPZ015866 supplier, PRMTs, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.